SPLISH (splish.dk) er en dansk online markedsplads, der samler møbler, belysning, kunst og boligtilbehør – både nyt og preloved. Vi arbejder udelukkende sammen med professionelle forhandlere og lægger vægt på at udvælge et sortiment, hvor kvalitet og design er i centrum. På SPLISH finder man både klassiske værker fra anerkendte designere og særligt udvalgte genstande, som giver hjemmet personlighed. Vi ønsker at skabe et sted, hvor man kan opdage møbler og genstande, der ikke bare fylder en funktion, men også fortæller en historie og tilføjer karakter til indretningen. En stor del af vores sortiment er preloved – det vil sige brugte produkter i god stand, som får nyt liv gennem SPLISH. Det gør det muligt at vælge møbler og kunst, der både er smukke og bæredygtige, og som rummer en historie fra tidligere hjem. Vi ser det som en naturlig måde at kombinere æstetik og ansvarlighed på. Det, der adskiller SPLISH fra andre platforme, er vores kuratering. Vi stræber efter at samle et udvalg, der både rummer værdi for samlere, entusiaster og dem, der blot ønsker at finde noget særligt til deres hjem. Sortimentet spænder fra møbler og lamper til kunst og boligtilbehør – altid med et fokus på godt håndværk, stærkt formsprog og en rød tråd i kvaliteten. SPLISH er tænkt som et roligt alternativ til masseplatforme: et sted hvor man kan gå på opdagelse og finde ting, der varer ved. For os handler det ikke kun om at købe og sælge, men også om at formidle design, håndværk og den historie, der følger med.

reGenics is a marine biotech company that leverage the science of unfertilized salmon roe to combat a global health problem: wound healing, diabetic ulcers and psoriasis. The company was one of the very few that was given the seal of excellence from EU, which makes it highly valued by associated and potential partners. One of them being a global well-known wound healing company , which also makes the case for possible exit opportunities in this intriguing investment case.

COACH Solutions optimizes vessels’ performance through monitoring and analysis. We keep operators updated throughout the voyage with unified reporting and energy deviation alerts. - We were developed by an experienced ship owner and operator. - We are a combination of naval architects and seafarers, based in Copenhagen and Mumbai. - We strive to be dynamic and flexible to adapt to our clients' needs.

The Product Eyecheck System is a modular SaaS platform that effectively enables sharing of clinical imaging, referrals, and other clinical correspondence instantly and securely between healthcare professionals, such as optometrists, eye doctors, and hospitals. By digitizing the patient journey we enable quicker treatments and fewer patient queues as we can process more patients with uncomplicated diagnoses more effectively. The Problem The prevalence of the most common retinal diseases, age-related macular degeneration (AMD) and diabetic retinopathy (DR), is rising in industrialized countries. In addition to demographic changes, this trend is also partly driven by growing numbers of patients with diabetes. This is increasing the workload in hospital ophthalmic units, and public ophthalmologists leading to waiting times of up to 12 months in Norway. This in turn increases the risk for serious eye damage in the general population at risk. The Solution Eyecheck System is a modular SaaS platform that shares clinical imaging, referrals, and other clinical correspondence securely and instantly between healthcare professionals. This in turn enables decentralized controls and diagnosis of patients even in rural areas with sub-optimal eye specialist coverage. Decentralized controls and screenings are made possible due to the vast amount of geographically spread retina imaging devices in over 600 optometrist locations throughout Norway alone. In addition to that, there is a wide-ranging discrepancy of competence levels across the profession of optometrists, where such a service would benefit both the patients and the optometrists. The reason why We are passionate about Eyecare and want to avoid blindness and other serious eye complications in Europe by digitizing the patient journey and creating a modern, more sustainable way to help patients get better. Our founder is an ophthalmologist (eye doctor) in Akershus and embarked on this journey due to his own experience when meeting patients that waited unnecessarily long on their appointment and ultimately an uncomplicated diagnosis.

We are on a mission to enable product professionals across the globe to create better and more sustainable products. The products that surround us every day, from your phone to the equipment needed to provide critical medicine to patients in need. Our unique Robust Design suite integrating directly with the designers’ 3D data provides actionable analysis results and design recommendations. Powered by Robust Design, we unlock design improvements that can be transformed into our 4 core offerings. Higher quality through smarter design solutions. Faster development through increased productivity. Lower cost through simpler design. Greener products by design Joining the RD8 team means you’ll be jumping to the forefront of the robust design technology field, helping create software that will be used by mechanical product development professionals from multiple industries all over the world. Your work will power real product solutions. Our ambition is to ultimately offer generative design to the global community to make smarter, faster, simpler products that are also more sustainable. The road there requires a deep respect and understanding of our partners’ businesses and the ability to create solutions every step of the way, growing with our partners and inside our team. We are humble, but confident in this endeavour. Our power is not in the size of our ranks, but in our ability to see through design complexity and transform it into tangible design challenges that can be objectively solved. This is how we move from our own minds and into the toolbox of every product professional out there.

We are developing a painless treatment for chronic wounds to help prevent amputations among diabetic patients and other chronic wound patients, thus minimising the need for antibiotics and preventing painful medical procedures. Chronic wounds are accounting for ~5% of the total US healthcare expenditure and result in an amputation every 30s worldwide.

Applying our expertise in machine learning. ML as a Service We build smart tools that helps you step closer to decision. We are a development company that creates and transforms business solutions, products, and enterprises to drive growth today and into the future. So far we have developed following: Churn Prevention and Churn Prediction regarding students and members Q-MATCH An algorithm for searching candidates with the right skills for job on the database. This tool dive into free text with a job description and by understanding the meaning, needs and requirements of the words, it will compare the text and find the best candidate on the database. You can turn everything around find the best job for the candidate. Save time and find the candidates you are looking for and get them prioritized from the best and down. This tool will soon be a part of Jobnet and Momentum, a system used by job consultants in the jobcenters. HR MATCH Tool for handling job applications by a job advertisement with no bias 1. Insert all or most necessary text from job ad in box on website 2. Upload CVs and applications on the website 3. Click on 'Match' and see priority list 4. Export CSV with best job matces - best profiles for the job The system can read and prioritize without prejudice, racism, religion, age and gender involved - equally good for each applicant. No human can do that :-)

Tasty Coconut was founded because we want to make eating fruits more colorful and fun. We import exciting and different foods because we want to show consumers that it doesn't have to be boring and monotonous to eat more greens - especially fruits. We focus on ecology, biodynamic production, tree-ripened fruits and freshly harvested vegetables. That is why we work with smaller farms from all over the world, so that we ensure that the road from farm to fork is as short as possible. The majority of our selection will always be organic and we are moving towards becoming 100% organic and biodynamic.

COBO Technologies is a fast-growing start-up company based in Copenhagen, Denmark, that specializes in products and services for Quality Control (QC) of CRISPR modified cells and animals. The team behind COBO comes from senior positions in science, commercial and operation, with more than 10 years experience in the CRISPR field. Within the last 5 years, the CRISPR field has developed from more than 100 publications per year to now more than 5,000 publications per year and the number of ongoing clinical trials using a CRISPR tool is now more than 60. In 2020 two CRISPR scientists received the Nobel Prize in Chemistry for their CRISPR inventions, proving that this is a fast-growing field which is now moving from research to clinics. In consequence, there is a need for platforms that can support efficient QC of CRISPR cells. In more general terms, there is a need to understand what are the safety effects of altering DNA with CRISPR — hitting the right target gene, checking how efficient the DNA change is, and investigating other DNA changes that were not expected. Most of the solutions offered today for cell/DNA analysis are not developed specifically for CRISPR applications. They are expensive, lack sensitivity and are time-consuming and they are done by service companies with no/or little knowledge about CRISPR. Based on our experience from the CRISPR field and feedback from our network in the EU and US, we have developed proprietary platforms that can support the current needs for QC of CRISPR cells. Including both proven reagents for sample preparation, cell analysis and bioinformatics, this is the first full-package solution developed specifically for CRISPR clients. In addition, it combines low cost, high sensitivity and fast delivery time - 3 factors essential for our clients. We have used the past year to build up a scalable operation in Denmark in a low-risk setup and are now ready to speed up the growth first in the EU and then later 2021 in the US. In addition, we will also start the initial preparation of our first development project for a clinical application at the end of 2021. Since the start 2018, COBO has supported more than 15 clients in both EU and US, including leading pharma companies and some of the leading universities in the world. We have developed unique platforms, we have clients every week, we have the network and we have the skills to be a major player in the global CRISPR field and be part of the development of future CRISPR Medicine to treat genetic diseases. As of today, COBO Technologies is backed by an angel investor.

Mads Olesen Holdings is owned by entrepreneur Mads Andreas Olesen. After selling his first companies for more than 100 mio. kroner, he now invests in startups, real estate and more through Mads Olesen Holdings (CVR: 36917997) and subsidiaries. In 2020, Mads Olesen Holdings invested in more than 50 ecommerce businesses through its investment in MXNEY.io, that specializes in alternative ecommerce funding. In 2021, the holding company is looking to add 10 properties to its current portfolio of 19 rental properties.

For 4 years we have been developing an innovative visual data collection solution that transforms operations and analytics within any organisation that carries out inspections. Our customers believe that what we do is unique and we love the fact that every one of our customers has renewed their Captego subscription every year. We are a Danish company that’s growing quickly throughout Europe. We operate in the UK, have a remote team spread throughout most of Europe and it won’t be long before we have customers in new European markets. We use English for all of our internal communication. We don’t mind where in Europe you’re based or what time you get out of bed, we only care that you want Captego to be a success as much as our customers do.

Finuprise is developing an app that helps people make smart investments into stocks and funds with social and environmental causes 84% of stocks belong to the wealthiest 10%, and women invest 40% less than men on average. How can we make the world better if decisions lie in the financial gatekeepers’ hands? The time to act is now, and finuprise is the tool to make change happen. Money talks, so let's be loud

We back bold entrepreneurs in their earliest stages and help shape the foundation of their aspirations. We classify investments into three categories; BUILD, SCALE, and FOMO. Building cases are companies that are so early that the company might not even be registered with the authorities yet. It’s merely an idea that we need to shape together, right from the beginning. Here we put in lots of hours and enough capital to build a minimum viable product and test the product on the market. If successful, we move to a scale-up phase investing more money and/or raise capital from external investors. SCALE cases are more developed. The first team is there, and they are close to a product-market fit. We help build the foundation with capital, advisory and agreed-upon milestones within, e.g., legal work, growth hacking, or strategy. Finally, yes, we do also invest in FOMO cases with only capital…

Today’s Pharma communications teams are focused on finding novel approaches in engaging stakeholders and providing more personalized experiences. Customer preferences have changed. Marketing & Sales can no longer produce content in campaign cycles – markets move fast and information is omnipresent. Snakker™ is a company that cares deeply about creating personalized and engaging digital experiences for healthcare professionals and those marketing teams who communicate with them. In support of this objective we have built a digital experience platform, Snakker™, which helps our customer brands to create personalized video-based content that is: Easily digestible and rewarding for customers Rewards substance over form content Designed for qualitative analysis Socially where your customers are Ready to respond to change We are an innovative, multicultural and forward-thinking company that places an emphasis on fostering a work environment that harbors these values to the benefit of our customers and the industry in which they operate.

Our vision is a world where good ideas become successful. Because we believe that too many good ideas and passionate entrepreneurs fall short due to the wrong reasons - we are here to change this. With our hands-on approach and by continuously challenging ourselves and our clients, we transform good ideas into successful companies.